ADC Therapeutics S.A. struggles with capital efficiency, having a Return on Invested Capital (ROIC) of -54.62% versus its Weighted Average Cost of Capital (WACC) of 20.44%.Ciena Corporation (CIEN) and Sanmina Corporation (SANM) show more favorable financial positions, with Sanmina achieving a ROIC that exceeds its WACC.COMSovereign Holding Corp. (COMS), Altair Engineering Inc. (ALTR), and ADTRAN Holdings, Inc. (ADTN) also face challenges in capital efficiency, with COMS showing severe inefficiencies.ADC The ...